Sally C. Pipes
Commentary
Fans of Medicare for All Have an Ally in Biden
So far in his campaign for president, Democratic nominee Joe Biden has assiduously avoided endorsing Medicare for All — much to the chagrin of a growing number of Democrats. A recent Hill-HarrisX poll finds that 87 percent of Democrats favor Medicare for All. And numerous delegates to the convention voted ...
Commentary
Trump’s Drug Pricing Order Is A Costly Mistake
On Sunday, September 13, President Trump signed a “most-favored-nation” executive order to reduce U.S. drug prices. It instructs federal officials to set pharmaceutical reimbursements under Medicare Parts B and D equal to the lowest prices paid in other developed countries, including Canada, the United Kingdom, and France. The high cost of medications is a ...
Coronavirus
Sally C. Pipes Talks Healthcare Insurance on the Rod Arquette Show
Sally Pipes, President and CEO of the Pacific Research Institute joins Rod to discuss the struggles some people are having with health insurance during the coronavirus pandemic.
Commentary
California should not get into the drug manufacturing business
In an attempt to lower Californians’ prescription drug costs, lawmakers just passed a bill that would allow the state government to contract with pharmaceutical manufacturers to produce generic drugs. Gov. Gavin Newsom’s signature is all but guaranteed before the end of the month. Golden State politicians aren’t the only ones ...
Commentary
Medicare for none – these are the reforms we need to keep program solvent
Democratic presidential nominee Joe Biden is proposing to expand Medicare by lowering the eligibility age from 65 to 60. But the program can’t afford the bill for its existing crop of beneficiaries, much less the $100 billion that would be required to enroll 22 million more under Biden’s plan. That’s among the conclusions to draw from a ...
Commentary
Blanket lockdowns for coronavirus are poor policy
Hundreds of health professionals recently urged government leaders to “hit the reset button” on Covid-19 by shutting the country down a second time. These blanket lockdowns pose a greater health risk to most people than the virus itself. Many Americans are so scared of Covid-19 they’ve stopped seeking medical care ...
California
Keep the government out of pharmaceutical drug manufacturing
Earlier this month, the California legislature passed a bill that would make the Golden State the first in the nation to establish its own line of generic drugs. Gov. Gavin Newsom is expected to sign the bill into law by the end of the month. The measure’s architects argue that ...
Commentary
Coronavirus lockdown benefits remain dubious as costs continue to mount
Roughly four in ten Americans report that they experienced reduced access to medical care because of COVID-19, according to a new survey from the Centers for Disease Control and Prevention. The report is just the latest evidence that, from the standpoint of public health, the lockdowns that public officials have ...
Commentary
The Remdesivir Patent Isn’t State Property
Nearly three dozen attorneys general are attempting a legal act of theft. This month, attorneys general from 31 states, American Samoa, Guam and the District of Columbia sent a letter to the heads of the U.S. Department of Health and Human Services, the National Institutes of Health and the Food ...
Commentary
Hey, GOP: Run on transparency in healthcare
Republicans have concluded their national convention without offering a detailed policy plan for the next four years. Instead, they have stuck with their 2016 platform and offered seven bullet points outlining their priorities when it comes to healthcare. Among those seven are promises to reduce health insurance premiums and end surprise medical bills. They ...
Fans of Medicare for All Have an Ally in Biden
So far in his campaign for president, Democratic nominee Joe Biden has assiduously avoided endorsing Medicare for All — much to the chagrin of a growing number of Democrats. A recent Hill-HarrisX poll finds that 87 percent of Democrats favor Medicare for All. And numerous delegates to the convention voted ...
Trump’s Drug Pricing Order Is A Costly Mistake
On Sunday, September 13, President Trump signed a “most-favored-nation” executive order to reduce U.S. drug prices. It instructs federal officials to set pharmaceutical reimbursements under Medicare Parts B and D equal to the lowest prices paid in other developed countries, including Canada, the United Kingdom, and France. The high cost of medications is a ...
Sally C. Pipes Talks Healthcare Insurance on the Rod Arquette Show
Sally Pipes, President and CEO of the Pacific Research Institute joins Rod to discuss the struggles some people are having with health insurance during the coronavirus pandemic.
California should not get into the drug manufacturing business
In an attempt to lower Californians’ prescription drug costs, lawmakers just passed a bill that would allow the state government to contract with pharmaceutical manufacturers to produce generic drugs. Gov. Gavin Newsom’s signature is all but guaranteed before the end of the month. Golden State politicians aren’t the only ones ...
Medicare for none – these are the reforms we need to keep program solvent
Democratic presidential nominee Joe Biden is proposing to expand Medicare by lowering the eligibility age from 65 to 60. But the program can’t afford the bill for its existing crop of beneficiaries, much less the $100 billion that would be required to enroll 22 million more under Biden’s plan. That’s among the conclusions to draw from a ...
Blanket lockdowns for coronavirus are poor policy
Hundreds of health professionals recently urged government leaders to “hit the reset button” on Covid-19 by shutting the country down a second time. These blanket lockdowns pose a greater health risk to most people than the virus itself. Many Americans are so scared of Covid-19 they’ve stopped seeking medical care ...
Keep the government out of pharmaceutical drug manufacturing
Earlier this month, the California legislature passed a bill that would make the Golden State the first in the nation to establish its own line of generic drugs. Gov. Gavin Newsom is expected to sign the bill into law by the end of the month. The measure’s architects argue that ...
Coronavirus lockdown benefits remain dubious as costs continue to mount
Roughly four in ten Americans report that they experienced reduced access to medical care because of COVID-19, according to a new survey from the Centers for Disease Control and Prevention. The report is just the latest evidence that, from the standpoint of public health, the lockdowns that public officials have ...
The Remdesivir Patent Isn’t State Property
Nearly three dozen attorneys general are attempting a legal act of theft. This month, attorneys general from 31 states, American Samoa, Guam and the District of Columbia sent a letter to the heads of the U.S. Department of Health and Human Services, the National Institutes of Health and the Food ...
Hey, GOP: Run on transparency in healthcare
Republicans have concluded their national convention without offering a detailed policy plan for the next four years. Instead, they have stuck with their 2016 platform and offered seven bullet points outlining their priorities when it comes to healthcare. Among those seven are promises to reduce health insurance premiums and end surprise medical bills. They ...
